Information  X 
Enter a valid email address

Tavistock Investment (TAVI)

  Print   

Monday 21 March, 2022

Tavistock Investment

Total Voting Rights & AIM Rule 17

RNS Number : 3635F
Tavistock Investments PLC
21 March 2022
 

Tavistock Investments Plc

 

("Tavistock" or the "Company")

 

Total Voting Rights & AIM Rule 17

 

21 March 2022

 

Further to the announcement made on 21 February 2022, Tavistock announces that the 21,219,847 ordinary shares of 1 penny each ("Ordinary Shares") purchased by the Company have now been cancelled.

 

Accordingly, the total number of voting rights in the Company is now 557,677,576 which number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Company also announces, pursuant to AIM Rule 17, that the percentage interest in the issued shares held by two significant shareholders has moved through a percentage point as a consequence of this reduction in the number of shares in issue and can now be summarised as follows. There has been no change in their individual interests in Ordinary Shares.

 

Shareholder

Interest in Ordinary Shares

% of issued share capital

Brian Raven (Chief Executive)

68,759,362

12.3

Andrew Staley

55,950,204

10.0




 

 

 

For further information

 

Tavistock Investments Plc

Oliver Cooke

Brian Raven

 

Tel: 01753 867000

Allenby Capital Limited (Nominated adviser and broker)

Corporate Finance: Nick Naylor, Liz Kirchner, Freddie Wooding

Sales and Corporate Broking: Tony Quirke

 

Tel: 020 3328 5656

Powerscourt

Gilly Lock

Chloe Retief

 

Tel: 07711 380 007

   020 7250 1446

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRSEMFASEESEFD

a d v e r t i s e m e n t